SCHEMBL6351833

SCHEMBL6351833

Clc1cccc(Nc2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 1/20 0.49
RAPGEF4 Q8WZA2 1/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
TP53 P04637 1/20 0.46
P2RY1 P47900 1/20 0.46
GAA P10253 2/20 0.45
EPHX1 P07099 1/20 0.44
EPHX2 P34913 1/20 0.44
CBS P35520 1/20 0.44
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
HTR3A P46098 1/20 0.44
ROCK1 Q13464 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1686631 0.87 FADS1 (0.59) FADS1KMT2AMEN1MAPTALDH1A1
SCHEMBL12614443 0.84 RAPGEF4 (0.59) RAPGEF4KMT2AMEN1MAPTLMNA
SCHEMBL331059 0.83 ALDH1A1 (0.59) RAPGEF4KMT2AMEN1MAPTALDH1A1
SCHEMBL6076594 0.80 EPHX1 (0.57) RAPGEF4KMT2AMEN1MAPTLMNA
SCHEMBL30342506 0.80 MEN1 (0.68) FADS1KMT2AMEN1MAPTALDH1A1
SCHEMBL3951892 0.80 MEN1 (0.68) FADS1KMT2AMEN1MAPTALDH1A1
SCHEMBL457521 0.80 MEN1 (0.79) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL16566494 0.80 ALDH1A1 (0.71) KMT2AMEN1MAPTALDH1A1GAA
SCHEMBL22824462 0.78 MAPT (0.53) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL7913356 0.78 HPGD (0.59) FADS1KMT2AMEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6936607-B2 2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety H. LUNOBECK A/S (DK) 2005-08-30 US disclosed